Assessment of glucose-6-phosphate dehydrogenase activity using CareStart G6PD rapid diagnostic test and associated genetic variants in Plasmodium vivax malaria endemic setting in Mauritania

BACKGROUND: Primaquine is recommended by the World Health Organization (WHO) for radical treatment of Plasmodium vivax malaria. This drug is known to provoke acute hemolytic anemia in individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency. Due to lack of data on G6PD deficiency, the us...

Descripción completa

Detalles Bibliográficos
Autores principales: Djigo, Oum kelthoum Mamadou, Bollahi, Mohamed Abdallahi, Hasni Ebou, Moina, Ould Ahmedou Salem, Mohamed Salem, Tahar, Rachida, Bogreau, Hervé, Basco, Leonardo, Ould Mohamed Salem Boukhary, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746352/
https://www.ncbi.nlm.nih.gov/pubmed/31525211
http://dx.doi.org/10.1371/journal.pone.0220977

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746352/
https://www.ncbi.nlm.nih.gov/pubmed/31525211
http://dx.doi.org/10.1371/journal.pone.0220977

Ejemplares similares